Under the terms of the deal, ‌Lantheus' shareholders will get $102.50 per share in cash when the deal closes, along with the ...

Supernus Pharma and Indivior have signed an all-stock merger agreement that would establish a new company, focused on central ...

Novartis paid out $195 million in 2020 to settle a criminal claim brought by the federal government – at the time, the ...

Analysts said the ZEUS failure makes ziltivekimab a high-risk asset and increases the pressure on Novo Nordisk to carry out ...

Agentic AI represents a bridge between predictive, generative, and autonomous systems. Building that bridge to last requires ...

There are rumours that a pharma 'mega-merger' – between AstraZeneca and Bristol Myers Squibb – is in the offing, ending several years without this type of deal. A report in the Financial Times ...

Ireland is attracting major investment from the largest pharma companies in the world. Ben Hargreaves finds out how the country has become one of the most significant locations in Europe for ...

After nearly a decade in the role, Guido Oelkers is stepping down as chief executive of Swedish biopharma group Sobi to take ...